Research Group Leader Senior, Peter Lukavsky Research Group
office: bldg. E35/1S024
Kamenice 753/5
625 00 Brno
| phone: | +420 549 49 5076 |
|---|---|
| e‑mail: |
|
| social and academic networks: |
|---|
| MU Researcher: | Mgr. PharmDr. Peter Lukavsky, Dr. rer. nat. |
|---|---|
| MU Faculty or unit: | Central European Institute of Technology |
| Project Period: |
1/2022 — 12/2024
|
| Investor: |
Czech Science Foundation
/
Standard Projects
|
| MU Researcher: | Mgr. PharmDr. Peter Lukavsky, Dr. rer. nat. |
|---|---|
| MU Faculty or unit: | Central European Institute of Technology |
| Project Period: |
7/2021 — 12/2024
|
| Investor: |
European Union
/
Horizon 2020
|
| MU Researcher: | Mgr. PharmDr. Peter Lukavsky, Dr. rer. nat. |
|---|---|
| MU Faculty or unit: | Central European Institute of Technology |
| Project Period: |
1/2018 — 6/2021
|
| Investor: |
Czech Science Foundation
/
Standard Projects
|
| MU Researcher: | Mgr. PharmDr. Peter Lukavsky, Dr. rer. nat. |
|---|---|
| MU Faculty or unit: | Central European Institute of Technology |
| Project Period: |
1/2015 — 12/2020
|
| Investor: |
EMBO (European Molecular Biology Organization)
/
EMBO Projects
|
| MU Researcher: | Mgr. PharmDr. Peter Lukavsky, Dr. rer. nat. |
|---|---|
| MU Faculty or unit: | Central European Institute of Technology |
| Project Period: |
3/2014 — 2/2018
|
| Investor: |
European Union
/
7th Specific RTD Programme
|
| MU Researcher: | Mgr. PharmDr. Peter Lukavsky, Dr. rer. nat. |
|---|---|
| MU Faculty or unit: | Central European Institute of Technology |
| Project Period: |
1/2015 — 12/2017
|
| Investor: |
Czech Science Foundation
/
Standard Projects
|